IP Library Granted Patent US 7,875,586
Granted Patent B2
US 7,875,586 · App. 10/539,212 · Granted Jan 25, 2011

Treatment of metastatic colon cancer with b-subunit of shiga toxin

Assignee: The Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,586
App. No.
10/539,212
Granted
Jan 25, 2011
Kind
B2
Abstract

The present invention relates to compositions and methods for treating invasive or metastatic cancer, particularly metastatic colon cancer using the B-submit of shiga toxin. The invention further provides methods of identifying compounds usefully for the treatment of invasive or metastatic cancer, particularly metastatic colon cancer.

Claims (10)

1. A method of reducing, or inhibiting invasiveness and metastasis of tumor cells in a subject, wherein the tumor cells produce Gb 3 , comprising administering to the subject a therapeutically effective amount of a Stx1B-subunit of Shiga toxin.

2. The method of claim 1 , wherein the tumor cells are colon tumor cells.

3. The method of claim 1 , wherein the tumor cells are from a tissue selected from the group consisting of: colon, lung, brain, skin, ovary, pancreas, liver, stomach, bladder, bone, testicle, uterus, adipose tissue, throat, kidney, tongue, pituitary gland, thyroid, lymphoid tissue, eye, and cervix.

4. The method of claim 1 , wherein the therapeutically effective amount of the Stx1B-subunit of Shiga toxin is administered prior to the onset of metastasis by the tumor cells.

5. The method of claim 1 , wherein the therapeutically effective amount of the B-subunit of Shiga toxin is administered subsequent to the onset of metastasis by the tumor cells.

6. The method of claim 1 , further comprising administering to the subject a therapeutically effective amount of radiation.

7. The method of claim 1 , further comprising administering to the subject a therapeutically effective amount of at least one chemotherapeutic agent.

8. The method of claim 1 , wherein the subject is a human.

9. The method of claim 1 , wherein the Stx1B-subunit of Shiga toxin is conjugated to a therapeutic moiety.

10. A method of reducing, or inhibiting invasiveness and metastasis of colon tumor cells in a subject, wherein the tumor cells produce Gb 3 , comprising administering to the subject a therapeutically effective amount of a Stx1B-subunit of Shiga toxin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2010
From: KOVBASNJUK, OLGA N.; DONOWITZ, MARK
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 025504/0204 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Sep 24, 2008
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021578/0649 →
Continuity (2)
Provisional Application 6043513900 · Dec 20, 2002
Related Publication 20070071772A1 · Mar 29, 2007